Emi E. Nakayama

Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression

Huanliang Liu, David Chao, Emi E. Nakayama et al. · Proceedings of the National Academy of Sciences · 1999 · 334 citations

An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies

Yafei Liu, Wai Tuck Soh, Jun-ichi Kishikawa et al. · Cell · 2021 · 285 citations · Full text

Vaccine Target, Viral Pathogenesis, Immunology +7

Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage

Tatsuo Shioda, Hiroyuki Kato, Yukano Ohnishi et al. · Proceedings of the National Academy of Sciences · 1998 · 180 citations · Full text

Immunology, Immune Regulation, Immunodominance +19

A Specific Region of 37 Amino Acid Residues in the SPRY (B30.2) Domain of African Green Monkey TRIM5α Determines Species-Specific Restriction of Simian Immunodeficiency Virus SIVmac Infection

Emi E. Nakayama, Hiroyuki Miyoshi, Yoshiyuki Nagai et al. · Journal of Virology · 2005 · 121 citations · Full text

Polymorphism in the Interleukin-4 Promoter Affects Acquisition of Human Immunodeficiency Virus Type 1 Syncytium-Inducing Phenotype

Emi E. Nakayama, Yoshihiko Hoshino, Xiaomi Xin et al. · Journal of Virology · 2000 · 93 citations · Full text